Proposed GMP design controls to be discussed at advisory committee meeting in June.
This article was originally published in The Gray Sheet
Executive Summary
PROPOSED DEVICE GMP DESIGN CONTROLS' EFFECT ON R&D will be examined at an upcoming meeting of FDA's Good Manufacturing Practices Advisory Committee, according to agency staffers. The agenda for the meeting, tentatively scheduled for June, likely will include discussion about whether design control provisions in the proposed revisions to GMP regulations would create an obstacle to manufacturers' R&D efforts.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.